Skip to content
HowShorted

CHEMBIO DIAGNOSTICS, INC. short interest in 2019

In 2019, CHEMBIO DIAGNOSTICS, INC.'s disclosed short interest ran from 0.38% of shares outstanding on 15 Jan 2019 to 1.18% on 31 Dec 2019, a change of +0.80 percentage points. The year's high was 1.23% on 31 Oct 2019 and its low 0.27% on 15 Apr 2019, averaging 0.70% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.71 days on 13 Dec 2019. Full history: CHEMBIO DIAGNOSTICS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023

Aggregate net short position time series for CHEMBIO DIAGNOSTICS, INC. in 2019

2019 in figures

Start of year
0.38% (15 Jan 2019)
End of year
1.18% (31 Dec 2019)
Change
+0.80 pp
High
1.23% (31 Oct 2019)
Low
0.27% (15 Apr 2019)
Average
0.70%
Highest days to cover
6.71 (13 Dec 2019)
SEC filings marked
8

Every report in 2019

CHEMBIO DIAGNOSTICS, INC. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 20190.38%1.60
31 Jan 20190.43%3.33
15 Feb 20190.37%1.12
28 Feb 20190.33%1.26
15 Mar 20190.31%1.00results (8-K)
29 Mar 20190.36%1.0010-K filed
15 Apr 20190.27%1.00
30 Apr 20190.41%1.51
15 May 20190.44%1.90results (8-K), 10-Q filed
31 May 20190.51%2.52
14 Jun 20190.68%4.36
28 Jun 20190.69%2.76
15 Jul 20190.68%5.45
31 Jul 20190.69%3.19
15 Aug 20190.78%3.6310-Q filed, results (8-K)
30 Aug 20190.79%3.40
13 Sep 20190.83%2.41
30 Sep 20190.93%2.81
15 Oct 20191.06%4.61
31 Oct 20191.23%5.96
15 Nov 20191.13%2.0210-Q filed, results (8-K)
29 Nov 20191.09%2.79
13 Dec 20191.21%6.71
31 Dec 20191.18%5.21

See also: CHEMBIO DIAGNOSTICS, INC.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.